中文版 | English

个人主页

关键词云

成果统计

合作作者[TOP 5]

  • Hu, Liang

    合作成果数：19

  • Chen, Haiquan

    合作成果数：17

  • Fang, Zhaoyuan

    合作成果数：17

  • Tong, Xinyuan

    合作成果数：16

  • Wong, Kwok-Kin

    合作成果数：14

访问统计


  总访问量
 1710
  访问来源
    内部： 5
    外部： 1705
    国内： 1406
    国外： 304

  年访问量
 253
  访问来源
    内部： 0
    外部： 253
    国内： 236
    国外： 17

  月访问量
 11
  访问来源
    内部： 0
    外部： 11
    国内： 11
    国外： 0

访问量

访问量

1. Personalized characterization of diseases using sample-specific ne.. [2143]
2. Negative regulation of DNMT3A de novo DNA methylation by frequentl.. [1474]
3. Lkb1 inactivation drives lung cancer lineage switching governed by.. [1354]
4. A novel PHD-finger protein 14/KIF4A complex overexpressed in lung .. [1313]
5. Identification of TRA2B-DNAH5 fusion as a novel oncogenic driver i.. [1298]
6. Heterogeneous Mechanisms of Primary and Acquired Resistance to Thi.. [1235]
7. A novel BMX variant promotes tumor cell growth and migration in lu.. [1196]
8. Lung cancer deficient in the tumor suppressor GATA4 is sensitive t.. [1098]
9. Cell Division Cycle 42 plays a Cell type-Specific role in Lung Tum.. [1083]
10. Cetuximab-modified mesoporous silica nano-medicine specifically ta.. [1049]
11. Landscape of transcriptional deregulation in lung cancer [1023]
12. The innate immune effector ISG12a promotes cancer immunity by supp.. [957]
13. Evolution from genetics to phenotype: reinterpretation of NSCLC pl.. [830]
14. Oxidative stress-triggered Wnt signaling perturbation characterize.. [814]
15. A systematic dissection of the epigenomic heterogeneity of lung ad.. [806]
16. Mechanistic Insights into Membrane Protein Clustering Revealed by .. [775]
17. Chromobox 4 facilitates tumorigenesis of lung adenocarcinoma Wnt/b.. [735]
18. Phase separation of EML4-ALK in firing downstream signaling and pr.. [728]
19. The Tumor Suppressor Interferon Regulatory Factor 2 Binding Protei.. [720]
20. In vivo CRISPR screening unveils histone demethylase UTX as an imp.. [701]
21. Enhancing the precision of genetic lineage tracing using dual reco.. [691]
22. Counteracting lineage-specific transcription factor network finely.. [685]
23. Cullin5 deficiency promotes small-cell lung cancer metastasis by s.. [674]
24. Lung regeneration by multipotent stem cells residing at the bronch.. [662]
25. Therapeutic targeting of the mevalonate-geranylgeranyl diphosphate.. [641]
26. In vivo miRNA knockout screening identifies miR-190b as a novel tu.. [620]
27. YAP Suppresses Lung Squamous Cell Carcinoma Progression via Deregu.. [609]
28. Pathological transition as the arising mechanism for drug resistan.. [577]
29. Specific gut microbiome signature predicts the early-stage lung ca.. [499]
30. Targeting HER2 Aberrations in Non-Small Cell Lung Cancer with Osim.. [491]
31. Squamous Transition of Lung Adenocarcinoma and Drug Resistance [489]
32. Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Dru.. [478]
33. Loss of TET reprograms Wnt signaling through impaired demethylatio.. [459]
34. 腺鳞癌转化在肺癌耐药中的功能和机制研究 [454]
35. Lkb1 deletion in periosteal mesenchymal progenitors induces osteog.. [450]
36. MAPK-Mediated YAP Activation Controls Mechanical-Tension-Induced P.. [449]
37. Keratin 14-high subpopulation mediates lung cancer metastasis pote.. [441]
38. Identification of TAZ as the essential molecular switch in orchest.. [423]
39. Integrative analysis of multi-omics data reveals the heterogeneity.. [422]
40. PI3K/Akt/mTOR signaling orchestrates the phenotypic transition and.. [420]
41. Genetic tracing uncovers the importance of epithelial-to-mesenchym.. [390]
42. Evidence, Mechanism, and Clinical Relevance of the Transdifferenti.. [366]
43. EML4-ALK fusions drive lung adeno-to-squamous transition through J.. [365]
44. Cryoablation triggers type I interferon-dependent antitumor immuni.. [364]
45. Proteogenomic characterization of small cell lung cancer identifie.. [362]
46. Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cance.. [355]
47. Multi-gradient Permutation Survival Analysis Identifies Mitosis an.. [331]
48. Bi-directional differentiation of single bronchioalveolar stem cel.. [321]
49. Targeting HSPA1A in ARID2-deficient lung adenocarcinoma [310]
50. Adeno-to-squamous transition drives resistance to KRAS inhibition .. [308]
51. Comments on 'Adeno-to-squamous transition drives resistance to KRA.. [304]
52. Lung stem cells in regeneration and tumorigenesis [299]
53. TET2-STAT3-CXCL5 nexus promotes neutrophil lipid transfer to fuel .. [288]
54. Nanog maintains stemness of Lkb1-deficient lung adenocarcinoma and.. [272]
55. Emerging horizons in cancer therapy: Squamous transition drives dr.. [258]
56. TIL Therapy in Lung Cancer: Current Progress and Perspectives [257]
57. Targeting RNA helicase DHX33 blocks Ras-driven lung tumorigenesis .. [256]
58. 肺癌耐药的新机制——肺癌的病理转化 [208]
59. TAZ inhibits SCLC metastasis through GALNT18-mediated O-glycosylat.. [187]
60. Integrative study of lung cancer adeno-to-squamous transition in E.. [184]
61. 缓解EGFR-TKI耐药的协同作用的氧化还原介孔硅纳米药物 [182]
62. UDA-seq: universal droplet microfluidics-based combinatorial index.. [61]
63. VGLL4 deficiency in T cells promotes tumor initiation and progress.. [10]

下载量

1. Personalized characterization of diseases using sample-specific ne.. [568]
2. Negative regulation of DNMT3A de novo DNA methylation by frequentl.. [436]
3. A novel PHD-finger protein 14/KIF4A complex overexpressed in lung .. [426]
4. Identification of TRA2B-DNAH5 fusion as a novel oncogenic driver i.. [417]
5. A novel BMX variant promotes tumor cell growth and migration in lu.. [401]
6. Lung cancer deficient in the tumor suppressor GATA4 is sensitive t.. [372]
7. Lkb1 inactivation drives lung cancer lineage switching governed by.. [339]
8. Heterogeneous Mechanisms of Primary and Acquired Resistance to Thi.. [337]
9. A systematic dissection of the epigenomic heterogeneity of lung ad.. [334]
10. Cetuximab-modified mesoporous silica nano-medicine specifically ta.. [331]
11. Cell Division Cycle 42 plays a Cell type-Specific role in Lung Tum.. [290]
12. Landscape of transcriptional deregulation in lung cancer [286]
13. Phase separation of EML4-ALK in firing downstream signaling and pr.. [264]
14. Mechanistic Insights into Membrane Protein Clustering Revealed by .. [260]
15. Pathological transition as the arising mechanism for drug resistan.. [235]
16. The innate immune effector ISG12a promotes cancer immunity by supp.. [215]
17. In vivo miRNA knockout screening identifies miR-190b as a novel tu.. [205]
18. Oxidative stress-triggered Wnt signaling perturbation characterize.. [201]
19. Counteracting lineage-specific transcription factor network finely.. [191]
20. Evolution from genetics to phenotype: reinterpretation of NSCLC pl.. [140]
21. Genetic tracing uncovers the importance of epithelial-to-mesenchym.. [65]
22. Cryoablation triggers type I interferon-dependent antitumor immuni.. [62]
23. Comments on 'Adeno-to-squamous transition drives resistance to KRA.. [50]
24. Multi-gradient Permutation Survival Analysis Identifies Mitosis an.. [41]
25. Lung regeneration by multipotent stem cells residing at the bronch.. [27]
26. Lkb1 deletion in periosteal mesenchymal progenitors induces osteog.. [9]
27. Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Dru.. [5]
28. Keratin 14-high subpopulation mediates lung cancer metastasis pote.. [3]
29. Integrative study of lung cancer adeno-to-squamous transition in E.. [3]
30. Enhancing the precision of genetic lineage tracing using dual reco.. [2]
31. Proteogenomic characterization of small cell lung cancer identifie.. [2]
32. Evidence, Mechanism, and Clinical Relevance of the Transdifferenti.. [1]
33. Targeting HER2 Aberrations in Non-Small Cell Lung Cancer with Osim.. [1]
34. Cullin5 deficiency promotes small-cell lung cancer metastasis by s.. [1]
35. Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cance.. [1]
36. Identification of TAZ as the essential molecular switch in orchest.. [1]
37. 腺鳞癌转化在肺癌耐药中的功能和机制研究 [1]
38. EML4-ALK fusions drive lung adeno-to-squamous transition through J.. [1]
39. Emerging horizons in cancer therapy: Squamous transition drives dr.. [1]
40. TET2-STAT3-CXCL5 nexus promotes neutrophil lipid transfer to fuel .. [1]
41. TIL Therapy in Lung Cancer: Current Progress and Perspectives [1]
42. TAZ inhibits SCLC metastasis through GALNT18-mediated O-glycosylat.. [1]
43. UDA-seq: universal droplet microfluidics-based combinatorial index.. [1]
44. VGLL4 deficiency in T cells promotes tumor initiation and progress.. [1]